Jun 17, 2015
Pierre Meulien will step down as president and CEO of Genome Canada on July 17 to become the executive director of the Innovative Medicines Initiative in Belgium. Meulien has been with Genome Canada since October 2010. The organization has begun a global search for his successor. Cindy Bell, a member of Genome Canada's executive management team, will serve as its president and CEO on an interim basis.